| RSS
Business center
Office
Post trade leads
Post
Rank promotion
Ranking
 
You are at: Home » News » International »

Cure Hepatitis C in 8 Weeks: Maviret, the Hepatitis C Drug with the Best Efficacy in the World, has

Increase font size  Decrease font size Date:2019-06-06   Views:467

The National Medical Products Administration of China (NMPA) has approved the marketing of AbbVie’s direct-acting antiviral (DAA) Maviret (glecaprevir/pibrentasvir) on May 15, 2019. The hepatitis C drug with the best efficacy in the world has thus entered China, which is used to treat adult patients with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection with or without compensated cirrhosis. With the advantage of curing hepatitis C in 8 weeks, Maviret was included in the second batch of clinically imperative overseas new drugs released by the NMPA upon “therapeutic advantages over marketed products”.

 
 
[ Search ]  [ ]  [ Email ]  [ Print ]  [ Close ]  [ Top ]

 
Total:0comment(s) [View All]  Related comment

 
Recomment
Popular
 
 
Home | About | Service | copyright | agreement | contact | about | SiteMap | Links | GuestBook | Ads service | 京ICP 68975478-1
Tel:+86-10-68645975           Fax:+86-10-68645973
E-mail:yaoshang68@163.com     QQ:1483838028